Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure

INTERNATIONAL JOURNAL OF CARDIOLOGY

卷:168

Letter

Dahl, Christen Peder^1,2,5  Aukrust, Pal^1,3,4  Nymo, Stale H.¹  Kjekshus, John²  Cleland, John G. F.⁶  McMurray, John J. V.⁷  Wikstrand, John⁸  Gullestad, Lars^2,5  Ueland, Thor^1,4 

[1] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, N-0027 Oslo, Norway

[2] Oslo Univ Hosp, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway

[3] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway

[4] Univ Oslo, Fac Med, Oslo, Norway

[5] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway

[6] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Dept Cardiol, Kingston Upon Hull, Yorks, England

[7] Univ Glasgow, Glasgow Cardiovasc Res Ctr, British Heart Fdn, Glasgow G12 8QQ, Lanark, Scotland

[8] Sahlgrens Univ Hosp, Gothenburg, Sweden

关键词: Heart failure;    Chemokine;    Predictor;    CXCL16;    Inflammation;   

DOI  :  10.1016/j.ijcard.2013.05.008

来源: Elsevier

【 授权许可】

Free